We are live on
!
Find out more
AFM
Armstrong Fleming & Moore Portfolio holdings
AUM
$236M
1-Year Est. Return
22.35%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+22.35%
3 Year Est. Return
+113.67%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$156M
AUM Growth
+$11.5M
(+7.9%)
Cap. Flow
-$1.15M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
60.2%
Holding
97
New
5
Increased
29
Reduced
27
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital Group International Focus Equity ETF
CGXU
|
+$504K |
| 2 |
T. Rowe Price Blue Chip Growth ETF
TCHP
|
+$442K |
| 3 |
Capital Group Dividend Value ETF
CGDV
|
+$330K |
| 4 |
NVO
Novo Nordisk
NVO
|
+$315K |
| 5 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$298K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$1.23M |
| 2 |
CAVA Group
CAVA
|
+$772K |
| 3 |
Saic
SAIC
|
+$544K |
| 4 |
Biogen
BIIB
|
+$374K |
| 5 |
W.P. Carey
WPC
|
+$356K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 22.76% |
| 2 | Technology | 20.9% |
| 3 | Financials | 5.39% |
| 4 | Consumer Staples | 4.58% |
| 5 | Communication Services | 4.57% |
Similar funds
CWL
PPWM
I
IGYL
JRPCML
GCM
AA
CF
Armstrong Fleming & Moore's Q2 2024 Portfolio in Review
As of Q2 2024, Armstrong Fleming & Moore held 97 positions worth $156M, up 7.9% from $144M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Armstrong Fleming & Moore's Q2 2024 filing shows 5 new, 29 increased, 27 reduced and 3 closed positions. Its largest new stake was FT Vest Fund of Buffer ETFs: 10,570 shares worth $306K. The largest sale was Berkshire Hathaway Class A, an estimated $1.23M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Armstrong Fleming & Moore's largest Q2 2024 buy was FT Vest Fund of Buffer ETFs: 10,570 shares worth $306K.
- Armstrong Fleming & Moore added most to Capital Group International Focus Equity ETF in Q2 2024, an estimated $504K increase.
- Armstrong Fleming & Moore's biggest Q2 2024 reduction was Berkshire Hathaway Class A, cutting an estimated $1.23M.
- Armstrong Fleming & Moore fully exited Biogen in Q2 2024, selling an estimated $374K.
- Armstrong Fleming & Moore's ten largest holdings make up 60% of its $156M portfolio in Q2 2024.
- Armstrong Fleming & Moore opened 5 new positions and closed 3 in Q2 2024.
- Armstrong Fleming & Moore's portfolio value rose 7.9% quarter-over-quarter to $156M.
Based on Armstrong Fleming & Moore's 13F filing for Q2 2024, filed 23 Jul 2024.